Meeder Asset Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Meeder Asset Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-43	Closed	-$1K	–	1825
2017 Q4	$1K	Buy	+43	New	+$846	﹤0.01%	1626
2017 Q2	–	Sell	-441	Closed	-$7K	–	2009
2017 Q1	$7K	Buy	+441	New	+$6.36K	﹤0.01%	978
2016 Q3	–	Sell	-270	Closed	-$9K	–	1023
2016 Q2	$9K	Buy	+270	New	+$8.49K	﹤0.01%	835

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Meeder Asset Management's DPLO Position: Q1 2018 in Review

Meeder Asset Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2018, closing a stake of 43 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in DPLO in Q2 2016 and held it in 3 quarters. The position peaked at $9K in Q2 2016. 201 funds tracked by Wall St. Rank hold DPLO as of Q1 2018.

Meeder Asset Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2018 after selling out during the quarter.
Meeder Asset Management sold 43 DIPLOMAT PHARMACY, INC. shares in Q1 2018, an estimated $1K.
Meeder Asset Management first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and held it in 3 quarters.
Meeder Asset Management's DIPLOMAT PHARMACY, INC. position peaked at $9K in Q2 2016.
201 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2018.

Based on Meeder Asset Management's 13F filing for Q1 2018, filed 3 May 2018.